| Identification | Back Directory | [Name]
1-(4-Aminophenyl)-3-methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepinehydrochloride | [CAS]
143692-48-2 | [Synonyms]
GYKI-53655 hydrate GYKI 53655 hydrochloride LY300168 hydrochloride hydrate 1-(4-Aminophenyl)-3-methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepinehydrochloride 5-(4-Aminophenyl)-8,9-dihydro-N,8-dimethyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide hydrochloride | [Molecular Formula]
C19H21ClN4O3 | [MDL Number]
MFCD01941362 | [MOL File]
143692-48-2.mol | [Molecular Weight]
388.848 |
| Hazard Information | Back Directory | [Uses]
GYKI 53655 Hydrochloride is a non-competitive AMPA antagonist,. | [Biological Activity]
GYKI-53655 also inhibits the kainate GluK3 homomeric and GluK2/3 heteromeric receptors. It exhibits anti-ischemicanti-convulsantand acute neuroprotective activity.''GYKI-53655 is an AMPA antagonist and noncompetitive negative allosteric modulator. | [storage]
Desiccate at RT |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|